✦ LIBER ✦

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer

✍ Scribed by Keun Seok Lee; Jungsil Ro; Byung-Ho Nam; Eun Sook Lee; Youngmee Kwon; Hye Soo Kwon; Ki Wook Chung; Han Sung Kang; Eun A Kim; Seok Won Kim; Kyung Hwan Shin; Seok-Ki Kim

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 285 KB
Volume: 109
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9672-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III randomized trial of sunitinib

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

✍ Carlos H. Barrios; Mei-Ching Liu; Soo Chin Lee; Laurence Vanlemmens; Jean-Marc F 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 289 KB

A phase III randomized trial of cyclopho

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

✍ M. C. Alonso; J. M. Tabernero; B. Ojeda; M. Llanos; C. Solà; M. A. Climent; M. A 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 788 KB

Five-year outcome for women randomised i

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

✍ Janine L. Mansi; Ann Yellowlees; Julian Lipscombe; Helena M. Earl; David A. Came 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 253 KB

Randomized phase III trial of trastuzuma

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB

A multicenter randomized phase II study

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients

✍ Jean-Yves Pierga; Suzette Delaloge; Marc Espié; Etienne Brain; Brigitte Sigal-Za 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 236 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views